\-\ Texto\\:\\ \ \(0\)\
\-\ fever\\ with\\ erythema\\ and\\ edema\\ overlying\\ left\\ eyelid\ \(0\)\
\-\ admission\\ with\\ 50\\%\\ undergoing\\ subsequent\\ sinusotomy\\ of\\ the\\ abscess\\ using\\ a\\ nasal\\ approach\\ \\(\\+\\/\\-\\)\\ drain\\ which\\ should\\ be\\ left\\ in\\ place\\ for\\ one\\ week\\.\\ \\ once\\ cultures\\ are\\ obtained\\ from\\ the\\ fluid\\,\\ iv\\ antibiotics\\ should\\ be\\ instituted\\ immediately\\ in\\ order\\ to\\ prevent\\ meningitis\\ and\\ overwhelming\\ systemic\\ infection\\.\\ \\ first\\ choice\\ antibiotic\\ for\\ children\\ includes\\ cefuroxime\\ 100mg\\/kg\\ per\\ day\\ divided\\ into\\ three\\ or\\ four\\ doses\\ parenterally\\.\\ \\ antibiotics\\ should\\ be\\ continued\\ empirically\\ with\\ most\\ sources\\ recommending\\ a\\ minimum\\ of\\ 10\\ days\\.\\ \\ repeat\\ of\\ sinus\\ ct\\ with\\ contrast\\ should\\ be\\ repeated\\ post\\ surgically\\ as\\ well\\ as\\ after\\ discontinuation\\ of\\ antibiotics\\ to\\ ensure\\ resolution\\.\ \(0\)\
\-\ rim\\ enhancing\\ homogenous\\ soft\\ tissue\\ density\\ within\\ the\\ left\\ ethmoid\\ sinus\\ which\\ is\\ eroding\\ through\\ the\\ lamina\\ papyracea\\.\\ \\ subperiosteal\\ abscess\\ 1\\.4x\\ 0\\.8cm\\ displacing\\ the\\ medial\\ rectus\\ muscle\\.\\ \\ soft\\ tissue\\ edema\\ in\\ medial\\ periorbital\\ region\\ with\\ inflammatory\\ changes\\ within\\ the\\ fat\\ of\\ the\\ conus\\.\\ \\ mild\\ proptosis\\ of\\ the\\ left\\ eye\\.\ \(0\)\
\-\ ethmoiditis\\ with\\ subperiosteal\\ abscess\\ of\\ the\\ left\\ medial\\ orbit\ \(0\)\
\-\ left\\ ethmoidal\\ sinusitis\\ with\\ abscess\\,\\ mucocele\\,\\ orbital\\ dermoid\\ cyst\\,\\ primary\\ conjunctival\\ cyst\\,\\ sweat\\ gland\\ cyst\\,\\ lacrimal\\ gland\\ cyst\\,\\ lymphangioma\\,\\ idiopathic\\ orbital\\ inflammation\\,\\ and\\ orbital\\ granulomatous\\ inflammations\ \(0\)\
\-\ 20\\ month\\ old\\ boy\\ with\\ recurrent\\ orbital\\ redness\\ and\\ bulging\\ eye\\.\ \(1\)\
\-\ abscesses\\ and\\ orbital\\ cellulitis\\ are\\ characterized\\ by\\ massive\\ accumulation\\ of\\ pmns\\.\\ \\ causative\\ agent\\ can\\ usually\\ be\\ demonstrated\\ with\\ staining\\ following\\ aspiration\\ or\\ surgical\\ drainage\\.\\ \\ these\\ usually\\ occur\\ in\\ conjunction\\ with\\ adjacent\\ sinusitis\\ but\\ may\\ also\\ occur\\ after\\ orbital\\ trauma\\ or\\ with\\ systemic\\ infections\\.\\ \\ offending\\ pathogens\\ include\\ a\\ variety\\ of\\ bacterial\\,\\ viral\\,\\ fungal\\,\\ and\\ parasitic\\ etiologies\\,\\ however\\,\\ most\\ cases\\ arise\\ from\\ bacterial\\ infections\\ of\\ the\\ sinuses\\.\\ \\ these\\ bacterial\\ pathogens\\ in\\ children\\ include\\ those\\ of\\ typical\\ uri\\ etiologies\\ such\\ as\\ s\\.\\ pneumoniae\\,\\ h\\.\\ influenza\\ and\\ s\\.\\ aureus\\.\\ \\ pseudomonas\\ and\\ e\\.\\ coli\\ are\\ also\\ less\\ common\\ causes\\ of\\ orbital\\ cellulitis\\.\\ \\ \ \(0\)\
\-\ patients\\ typically\\ present\\ with\\ the\\ sudden\\ onset\\ of\\ pain\\,\\ eyelid\\ edema\\,\\ conjunctival\\ hyperemia\\ and\\ chemosis\\ and\\ sometimes\\ proptosis\\,\\ diplopia\\,\\ increased\\ iop\\,\\ and\\ blepharoptosis\\.\\ \\ orbital\\ cellulitis\\ is\\ one\\ of\\ the\\ most\\ common\\ causes\\ of\\ proptosis\\ in\\ children\\ less\\ than\\ five\\.\\ \\ patients\\ may\\ also\\ experience\\ fever\\,\\ malaise\\,\\ and\\ leukocytosis\\ with\\ signs\\ of\\ sinusitis\\.\ \(0\)\
\-\ subperiosteal\\ abscess\\ is\\ a\\ purulent\\ foci\\ within\\ the\\ adjacent\\ subperiosteal\\ space\\ that\\ can\\ lead\\ to\\ abaxial\\ displacement\\,\\ local\\ tenderness\\,\\ and\\ a\\ possible\\ fluctuant\\ mass\\.\\ \\ abscess\\ formation\\ may\\ be\\ rapid\\ with\\ destruction\\ of\\ tissue\\ planes\\ depending\\ on\\ the\\ severity\\ of\\ the\\ offending\\ pathogen\\.\\ \\ clinical\\ clues\\ may\\ include\\ profound\\ proptosis\\ with\\ a\\ functional\\ deficit\\ in\\ the\\ absence\\ of\\ striking\\ concomitant\\ inflammatory\\ signs\\ such\\ as\\ chemosis\\ and\\ lid\\ injection\\.\\ \\ \ \(0\)\
\-\ \\ \ \(1082074\)\
\-\ typical\\ ct\\ features\\ of\\ a\\ subperiosteal\\ abscess\\ include\\ \\(\\+\\/\\-\\)\\ an\\ enhancing\\ capsule\\ with\\ smooth\\ contoured\\ periorbital\\ lesion\\ adjacent\\ to\\ an\\ opacified\\ sinus\\.\\ \\ cellulitis\\ would\\ appear\\ as\\ lid\\ edema\\,\\ sinus\\ opafication\\ with\\ mucosal\\ thickening\\.\\ \\ following\\ contrast\\ infusion\\,\\ periosteum\\ may\\ be\\ seen\\ to\\ enhance\\ therefore\\ giving\\ rise\\ to\\ an\\ enhancing\\ capsule\\ as\\ seen\\ in\\ this\\ patient\\.\ \(0\)\
\-\ complications\\ include\\ severe\\ septicemia\\ with\\ resultant\\ meningitis\\ and\\ cavernous\\ sinus\\ thrombosis\\;\\ however\\,\\ with\\ the\\ institution\\ of\\ immediate\\ incision\\ and\\ drainage\\ with\\ appropriate\\ iv\\ antibiotics\\ fatal\\ outcomes\\ have\\ dropped\\ dramatically\\ in\\ the\\ past\\ decade\\.\ \(0\)\
\-\ cavernous\\ sinus\\ thrombosis\\ would\\ present\\ with\\ headache\\,\\ nausea\\,\\ vomiting\\,\\ fever\\,\\ and\\ varying\\ levels\\ of\\ consciousness\\ in\\ addition\\ to\\ the\\ typical\\ signs\\ and\\ symptoms\\ of\\ orbital\\ cellulitis\\.\ \(0\)\
\-\ patients\\ should\\ be\\ monitored\\ while\\ hospitalized\\ for\\ worsening\\ symptoms\\ despite\\ antibiotic\\ treatment\\ in\\ order\\ to\\ prevent\\ these\\ fatal\\ outcomes\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ orbital\\:\\ 0\\.05960800719365797\ \(0\)\
\-\ subperiosteal\\:\\ 0\\.04714866001832578\ \(0\)\
\-\ cellulitis\\:\\ 0\\.041485692856888315\ \(0\)\
\-\ proptosis\\:\\ 0\\.03119259579171208\ \(0\)\
\-\ abscess\\:\\ 0\\.03090335573356188\ \(0\)\
\-\ sinus\\:\\ 0\\.030638813427867038\ \(0\)\
\-\ sinusitis\\:\\ 0\\.024236850064012782\ \(0\)\
\-\ pathogens\\:\\ 0\\.02295346063640014\ \(0\)\
\-\ should\\:\\ 0\\.022256605734385624\ \(0\)\
\-\ bacterial\\:\\ 0\\.021435623369981283\ \(0\)\
\-\ conjunctival\\:\\ 0\\.021284095852851154\ \(0\)\
\-\ offending\\:\\ 0\\.021284095852851154\ \(0\)\
\-\ antibiotics\\:\\ 0\\.020978538285428113\ \(0\)\
\-\ chemosis\\:\\ 0\\.020972624677020026\ \(0\)\
\-\ lid\\:\\ 0\\.020184513380232808\ \(0\)\
\-\ eyelid\\:\\ 0\\.019959046479948655\ \(0\)\
\-\ include\\:\\ 0\\.01958458732050888\ \(0\)\
\-\ outcomes\\:\\ 0\\.019186534133333523\ \(0\)\
\-\ \\+\\/\\-\\:\\ 0\\.019018908988276167\ \(0\)\
\-\ fatal\\:\\ 0\\.01885946400733031\ \(0\)\
\-\ periorbital\\:\\ 0\\.01856217061450114\ \(0\)\
\-\ children\\:\\ 0\\.018095855120408035\ \(0\)\
\-\ be\\:\\ 0\\.017225578082927177\ \(0\)\
\-\ typical\\:\\ 0\\.01679630732426469\ \(0\)\
\-\ s\\.\\:\\ 0\\.016368810242471173\ \(0\)\
\-\ edema\\:\\ 0\\.015796885551838502\ \(0\)\
\-\ etiologies\\:\\ 0\\.015483597974054833\ \(0\)\
\-\ may\\:\\ 0\\.015313140268775522\ \(0\)\
\-\ capsule\\:\\ 0\\.015117201574967556\ \(0\)\
\-\ cyst\\:\\ 0\\.01500896167337322\ \(0\)\
\-\ signs\\:\\ 0\\.014742038892088501\ \(0\)\
\-\ meningitis\\:\\ 0\\.014488535259126196\ \(0\)\
\-\ sinusotomy\\:\\ 0\\.014404441869226304\ \(0\)\
\-\ 100mg\\/kg\\:\\ 0\\.014404441869226304\ \(0\)\
\-\ parenterally\\:\\ 0\\.014404441869226304\ \(0\)\
\-\ recommending\\:\\ 0\\.014404441869226304\ \(0\)\
\-\ 1\\.4x\\:\\ 0\\.014404441869226304\ \(0\)\
\-\ 0\\.8cm\\:\\ 0\\.014404441869226304\ \(0\)\
\-\ ethmoiditis\\:\\ 0\\.014404441869226304\ \(0\)\
\-\ blepharoptosis\\:\\ 0\\.014404441869226304\ \(0\)\
\-\ abaxial\\:\\ 0\\.014404441869226304\ \(0\)\
\-\ opafication\\:\\ 0\\.014404441869226304\ \(0\)\
\-\ antibiotic\\:\\ 0\\.014290415579987522\ \(0\)\
\-\ fever\\:\\ 0\\.014172856012509637\ \(0\)\
\-\ order\\:\\ 0\\.013996467094160922\ \(0\)\
\-\ prevent\\:\\ 0\\.013858847860990575\ \(0\)\
\-\ \\,\\:\\ 0\\.013712437959209001\ \(0\)\
\-\ medial\\:\\ 0\\.013398527027402215\ \(0\)\
\-\ systemic\\:\\ 0\\.013359903938739077\ \(0\)\
\-\ infections\\:\\ 0\\.01327427527078475\ \(0\)\
\-\ inflammations\\:\\ 0\\.013271848436938813\ \(0\)\
\-\ adjacent\\:\\ 0\\.013244295314383663\ \(0\)\
\-\ enhancing\\:\\ 0\\.013137027121984115\ \(0\)\
\-\ cavernous\\:\\ 0\\.012952575686427716\ \(0\)\
\-\ as\\:\\ 0\\.012672328489158115\ \(0\)\
\-\ cefuroxime\\:\\ 0\\.012609323750487563\ \(0\)\
\-\ discontinuation\\:\\ 0\\.012609323750487563\ \(0\)\
\-\ septicemia\\:\\ 0\\.012609323750487563\ \(0\)\
\-\ thrombosis\\:\\ 0\\.011987006363245246\ \(0\)\
\-\ gland\\:\\ 0\\.011893361736577351\ \(0\)\
\-\ pseudomonas\\:\\ 0\\.011774641358713069\ \(0\)\
\-\ pathogen\\:\\ 0\\.011774641358713069\ \(0\)\
\-\ contoured\\:\\ 0\\.011774641358713069\ \(0\)\
\-\ eye\\:\\ 0\\.01171375753958141\ \(0\)\
\-\ drainage\\:\\ 0\\.011678991532375347\ \(0\)\
\-\ overwhelming\\:\\ 0\\.01147673031820007\ \(0\)\
\-\ minimum\\:\\ 0\\.01147673031820007\ \(0\)\
\-\ papyracea\\:\\ 0\\.01147673031820007\ \(0\)\
\-\ clues\\:\\ 0\\.01147673031820007\ \(0\)\
\-\ eroding\\:\\ 0\\.011224850122403898\ \(0\)\
\-\ iop\\:\\ 0\\.011224850122403898\ \(0\)\
\-\ fluctuant\\:\\ 0\\.011224850122403898\ \(0\)\
\-\ empirically\\:\\ 0\\.011006661572363827\ \(0\)\
\-\ pmns\\:\\ 0\\.011006661572363827\ \(0\)\
\-\ dramatically\\:\\ 0\\.011006661572363827\ \(0\)\
\-\ these\\:\\ 0\\.010901199470381569\ \(0\)\
\-\ causes\\:\\ 0\\.010871178751012456\ \(0\)\
\-\ patients\\:\\ 0\\.010841051957676597\ \(0\)\
\-\ ethmoidal\\:\\ 0\\.010642047926425577\ \(0\)\
\-\ influenza\\:\\ 0\\.010642047926425577\ \(0\)\
\-\ instituted\\:\\ 0\\.010486312338510013\ \(0\)\
\-\ pneumoniae\\:\\ 0\\.010486312338510013\ \(0\)\
\-\ occur\\:\\ 0\\.010477276564645551\ \(0\)\
\-\ dropped\\:\\ 0\\.010344136885912578\ \(0\)\
\-\ sweat\\:\\ 0\\.010213348147883924\ \(0\)\
\-\ causative\\:\\ 0\\.010213348147883924\ \(0\)\
\-\ iv\\:\\ 0\\.010190931168173508\ \(0\)\
\-\ doses\\:\\ 0\\.009979523239974327\ \(0\)\
\-\ lamina\\:\\ 0\\.009979523239974327\ \(0\)\
\-\ profound\\:\\ 0\\.009979523239974327\ \(0\)\
\-\ would\\:\\ 0\\.00993780025628134\ \(0\)\
\-\ tissue\\:\\ 0\\.009928535237512713\ \(0\)\
\-\ uri\\:\\ 0\\.009874068140076336\ \(0\)\
\-\ inflammatory\\:\\ 0\\.009684039033307267\ \(0\)\
\-\ most\\:\\ 0\\.009670760498667039\ \(0\)\
\-\ sources\\:\\ 0\\.009593267066666761\ \(0\)\
\-\ coli\\:\\ 0\\.009593267066666761\ \(0\)\
\-\ opacified\\:\\ 0\\.009593267066666761\ \(0\)\
\-\ hospitalized\\:\\ 0\\.009593267066666761\ \(0\)\
\-\ lacrimal\\:\\ 0\\.009509454494138083\ \(0\)\
\-\ conjunction\\:\\ 0\\.009509454494138083\ \(0\)\
\-\ striking\\:\\ 0\\.009509454494138083\ \(0\)\
\-\ less\\:\\ 0\\.009457320275564321\ \(0\)\
\-\ periosteum\\:\\ 0\\.009429732003665155\ \(0\)\
\-\ left\\:\\ 0\\.009373581071303086\ \(0\)\
\-\ hyperemia\\:\\ 0\\.009353718906222521\ \(0\)\
\-\ purulent\\:\\ 0\\.009353718906222521\ \(0\)\
\-\ displacing\\:\\ 0\\.00928108530725057\ \(0\)\
\-\ redness\\:\\ 0\\.00928108530725057\ \(0\)\
\-\ staining\\:\\ 0\\.00928108530725057\ \(0\)\
\-\ aureus\\:\\ 0\\.009211543453625086\ \(0\)\
\-\ infusion\\:\\ 0\\.009144840848199833\ \(0\)\
\-\ giving\\:\\ 0\\.009144840848199833\ \(0\)\
\-\ concomitant\\:\\ 0\\.009080754715596431\ \(0\)\
\-\ lymphangioma\\:\\ 0\\.009019087513010081\ \(0\)\
\-\ rise\\:\\ 0\\.009019087513010081\ \(0\)\
\-\ agent\\:\\ 0\\.008959663257828912\ \(0\)\
\-\ h\\.\\:\\ 0\\.008959663257828912\ \(0\)\
\-\ mucocele\\:\\ 0\\.008902324499967359\ \(0\)\
\-\ incision\\:\\ 0\\.008846929807686834\ \(0\)\
\-\ divided\\:\\ 0\\.008793351665819203\ \(0\)\
\-\ malaise\\:\\ 0\\.008741474707788842\ \(0\)\
\-\ such\\:\\ 0\\.008729845718434158\ \(0\)\
\-\ parasitic\\:\\ 0\\.008642414868219504\ \(0\)\
\-\ leukocytosis\\:\\ 0\\.008595049611890662\ \(0\)\
\-\ usually\\:\\ 0\\.00848015769237503\ \(0\)\
\-\ e\\.\\:\\ 0\\.00846067363437927\ \(0\)\
\-\ conus\\:\\ 0\\.008418230029145183\ \(0\)\
\-\ bulging\\:\\ 0\\.008418230029145183\ \(0\)\
\-\ monitored\\:\\ 0\\.008418230029145183\ \(0\)\
\-\ homogenous\\:\\ 0\\.008297138571377663\ \(0\)\
\-\ variety\\:\\ 0\\.008258690046197607\ \(0\)\
\-\ also\\:\\ 0\\.008257939184657604\ \(0\)\
\-\ decade\\:\\ 0\\.008221125473935028\ \(0\)\
\-\ resultant\\:\\ 0\\.008184405121235586\ \(0\)\
\-\ varying\\:\\ 0\\.008184405121235586\ \(0\)\
\-\ ethmoid\\:\\ 0\\.008148491874963077\ \(0\)\
\-\ diplopia\\:\\ 0\\.008148491874963077\ \(0\)\
\-\ ensure\\:\\ 0\\.008113351016758889\ \(0\)\
\-\ repeated\\:\\ 0\\.008078950021337595\ \(0\)\
\-\ rectus\\:\\ 0\\.008078950021337595\ \(0\)\
\-\ planes\\:\\ 0\\.00801224741591234\ \(0\)\
\-\ within\\:\\ 0\\.007990840237186674\ \(0\)\
\-\ massive\\:\\ 0\\.007979890181768255\ \(0\)\
\-\ following\\:\\ 0\\.007925744303598525\ \(0\)\
\-\ abscesses\\:\\ 0\\.007886494080722587\ \(0\)\
\-\ however\\:\\ 0\\.007775712599990427\ \(0\)\
\-\ drain\\:\\ 0\\.007687327712080371\ \(0\)\
\-\ functional\\:\\ 0\\.007687327712080371\ \(0\)\
\-\ experience\\:\\ 0\\.007660758233531711\ \(0\)\
\-\ institution\\:\\ 0\\.00760888127550135\ \(0\)\
\-\ severity\\:\\ 0\\.007583547637370688\ \(0\)\
\-\ in\\:\\ 0\\.00757413322147517\ \(0\)\
\-\ one\\:\\ 0\\.0075677496186622355\ \(0\)\
\-\ accumulation\\:\\ 0\\.007439278671446377\ \(0\)\
\-\ approach\\:\\ 0\\.007328080202091777\ \(0\)\
\-\ common\\:\\ 0\\.007308062784171233\ \(0\)\
\-\ immediate\\:\\ 0\\.007306720591687605\ \(0\)\
\-\ depending\\:\\ 0\\.007264821195260583\ \(0\)\
\-\ choice\\:\\ 0\\.007223969394271339\ \(0\)\
\-\ deficit\\:\\ 0\\.007203920223369681\ \(0\)\
\-\ mucosal\\:\\ 0\\.007203920223369681\ \(0\)\
\-\ cultures\\:\\ 0\\.007184114078708987\ \(0\)\
\-\ sinuses\\:\\ 0\\.007184114078708987\ \(0\)\
\-\ once\\:\\ 0\\.007145207789993761\ \(0\)\
\-\ sometimes\\:\\ 0\\.007107206381228619\ \(0\)\
\-\ consciousness\\:\\ 0\\.007088532041647535\ \(0\)\
\-\ surgically\\:\\ 0\\.007070068716069214\ \(0\)\
\-\ rapid\\:\\ 0\\.007051811688948094\ \(0\)\
\-\ orbit\\:\\ 0\\.007033756401061518\ \(0\)\
\-\ viral\\:\\ 0\\.007033756401061518\ \(0\)\
\-\ five\\:\\ 0\\.006963466556153526\ \(0\)\
\-\ symptoms\\:\\ 0\\.006959664957183462\ \(0\)\
\-\ characterized\\:\\ 0\\.006946356589050102\ \(0\)\
\-\ immediately\\:\\ 0\\.006929423930495287\ \(0\)\
\-\ nasal\\:\\ 0\\.006912664943293997\ \(0\)\
\-\ arise\\:\\ 0\\.006912664943293997\ \(0\)\
\-\ destruction\\:\\ 0\\.0068960761010325305\ \(0\)\
\-\ erythema\\:\\ 0\\.006863395273080455\ \(0\)\
\-\ undergoing\\:\\ 0\\.006847296749480763\ \(0\)\
\-\ soft\\:\\ 0\\.00680041426141683\ \(0\)\
\-\ place\\:\\ 0\\.0067844433494353455\ \(0\)\
\-\ fungal\\:\\ 0\\.006769100636445411\ \(0\)\
\-\ enhance\\:\\ 0\\.006753900648435096\ \(0\)\
\-\ granulomatous\\:\\ 0\\.006738840754472802\ \(0\)\
\-\ lead\\:\\ 0\\.006694476393253927\ \(0\)\
\-\ therefore\\:\\ 0\\.006595416553684589\ \(0\)\
\-\ aspiration\\:\\ 0\\.006581742943111851\ \(0\)\
\-\ appropriate\\:\\ 0\\.006581742943111851\ \(0\)\
\-\ repeat\\:\\ 0\\.0065681828077937205\ \(0\)\
\-\ injection\\:\\ 0\\.006515040337686597\ \(0\)\
\-\ despite\\:\\ 0\\.006489103492659979\ \(0\)\
\-\ sudden\\:\\ 0\\.006450954205083196\ \(0\)\
\-\ local\\:\\ 0\\.006413675319844354\ \(0\)\
\-\ dermoid\\:\\ 0\\.006365257349899303\ \(0\)\
\-\ idiopathic\\:\\ 0\\.006365257349899303\ \(0\)\
\-\ those\\:\\ 0\\.0063533737562243365\ \(0\)\
\-\ can\\:\\ 0\\.006334059975389116\ \(0\)\
\-\ overlying\\:\\ 0\\.006318232898020147\ \(0\)\
\-\ present\\:\\ 0\\.006307218150103532\ \(0\)\
\-\ contrast\\:\\ 0\\.006250900937280737\ \(0\)\
\-\ admission\\:\\ 0\\.006153043164570198\ \(0\)\
\-\ per\\:\\ 0\\.0061116741972756065\ \(0\)\
\-\ smooth\\:\\ 0\\.0061116741972756065\ \(0\)\
\-\ using\\:\\ 0\\.006061393709258035\ \(0\)\
\-\ four\\:\\ 0\\.006061393709258035\ \(0\)\
\-\ resolution\\:\\ 0\\.006022254426541544\ \(0\)\
\-\ continued\\:\\ 0\\.006012614357706269\ \(0\)\
\-\ foci\\:\\ 0\\.005993503181622623\ \(0\)\
\-\ displacement\\:\\ 0\\.00598403076710575\ \(0\)\
\-\ inflammation\\:\\ 0\\.005937475283781721\ \(0\)\
\-\ addition\\:\\ 0\\.005919218256660601\ \(0\)\
\-\ rim\\:\\ 0\\.005910165674347504\ \(0\)\
\-\ recurrent\\:\\ 0\\.00589220959334163\ \(0\)\
\-\ features\\:\\ 0\\.00589220959334163\ \(0\)\
\-\ absence\\:\\ 0\\.005805274893891524\ \(0\)\
\-\ an\\:\\ 0\\.005792474824925146\ \(0\)\
\-\ after\\:\\ 0\\.005777781707873211\ \(0\)\
\-\ formation\\:\\ 0\\.005763482668745038\ \(0\)\
\-\ levels\\:\\ 0\\.005763482668745038\ \(0\)\
\-\ appear\\:\\ 0\\.0057147033171932714\ \(0\)\
\-\ are\\:\\ 0\\.005710166041811773\ \(0\)\
\-\ includes\\:\\ 0\\.005628889535684372\ \(0\)\
\-\ nausea\\:\\ 0\\.005621307216147603\ \(0\)\
\-\ to\\:\\ 0\\.005582589652849494\ \(0\)\
\-\ complications\\:\\ 0\\.005532962083353035\ \(0\)\
\-\ seen\\:\\ 0\\.00551839089891402\ \(0\)\
\-\ worsening\\:\\ 0\\.005497516291504571\ \(0\)\
\-\ subsequent\\:\\ 0\\.005435589375506228\ \(0\)\
\-\ vomiting\\:\\ 0\\.005330978495171374\ \(0\)\
\-\ 50\\:\\ 0\\.005312088262489877\ \(0\)\
\-\ and\\:\\ 0\\.0052943825215358365\ \(0\)\
\-\ which\\:\\ 0\\.005212890807982186\ \(0\)\
\-\ 20\\:\\ 0\\.005020449732282706\ \(0\)\
\-\ muscle\\:\\ 0\\.005015220969650891\ \(0\)\
\-\ obtained\\:\\ 0\\.004963833497947454\ \(0\)\
\-\ typically\\:\\ 0\\.0049288002769705425\ \(0\)\
\-\ or\\:\\ 0\\.004909425240018174\ \(0\)\
\-\ headache\\:\\ 0\\.004795727839159801\ \(0\)\
\-\ boy\\:\\ 0\\.0047462774181796915\ \(0\)\
\-\ week\\:\\ 0\\.004741855258706255\ \(0\)\
\-\ thickening\\:\\ 0\\.004733046682505477\ \(0\)\
\-\ three\\:\\ 0\\.004706902333900181\ \(0\)\
\-\ 10\\:\\ 0\\.004706902333900181\ \(0\)\
\-\ possible\\:\\ 0\\.004702585324973974\ \(0\)\
\-\ first\\:\\ 0\\.004685430448996491\ \(0\)\
\-\ cases\\:\\ 0\\.004651651738531263\ \(0\)\
\-\ space\\:\\ 0\\.004618557201105612\ \(0\)\
\-\ density\\:\\ 0\\.004594168883758103\ \(0\)\
\-\ a\\:\\ 0\\.004536272243023217\ \(0\)\
\-\ past\\:\\ 0\\.004436600444356918\ \(0\)\
\-\ day\\:\\ 0\\.004432940897635506\ \(0\)\
\-\ onset\\:\\ 0\\.0044075510227535135\ \(0\)\
\-\ post\\:\\ 0\\.00439678926972597\ \(0\)\
\-\ while\\:\\ 0\\.004393217712176983\ \(0\)\
\-\ of\\:\\ 0\\.004378410814303487\ \(0\)\
\-\ clinical\\:\\ 0\\.004296257843245105\ \(0\)\
\-\ severe\\:\\ 0\\.004296257843245105\ \(0\)\
\-\ the\\:\\ 0\\.004292052956485114\ \(0\)\
\-\ days\\:\\ 0\\.004279533163679702\ \(0\)\
\-\ fat\\:\\ 0\\.004246588762878486\ \(0\)\
\-\ tenderness\\:\\ 0\\.004246588762878486\ \(0\)\
\-\ month\\:\\ 0\\.004188912648367009\ \(0\)\
\-\ from\\:\\ 0\\.004138678801157557\ \(0\)\
\-\ primary\\:\\ 0\\.004136248795581204\ \(0\)\
\-\ demonstrated\\:\\ 0\\.004097091474602888\ \(0\)\
\-\ infection\\:\\ 0\\.004058850611230077\ \(0\)\
\-\ with\\:\\ 0\\.00401484917955504\ \(0\)\
\-\ changes\\:\\ 0\\.0040017123794690536\ \(0\)\
\-\ fluid\\:\\ 0\\.003968364550006296\ \(0\)\
\-\ through\\:\\ 0\\.0039656160431713544\ \(0\)\
\-\ region\\:\\ 0\\.0039437928549661974\ \(0\)\
\-\ ct\\:\\ 0\\.0039062210895164803\ \(0\)\
\-\ trauma\\:\\ 0\\.003818641800258054\ \(0\)\
\-\ mild\\:\\ 0\\.0036768847286456486\ \(0\)\
\-\ than\\:\\ 0\\.003658576560323977\ \(0\)\
\-\ for\\:\\ 0\\.003574059552170172\ \(0\)\
\-\ increased\\:\\ 0\\.0034158248068621826\ \(0\)\
\-\ into\\:\\ 0\\.0033224287058165147\ \(0\)\
\-\ \\;\\:\\ 0\\.0033095117458375716\ \(0\)\
\-\ \\%\\:\\ 0\\.0032570605120032805\ \(0\)\
\-\ well\\:\\ 0\\.003158629008118711\ \(0\)\
\-\ have\\:\\ 0\\.0030235916313155094\ \(0\)\
\-\ but\\:\\ 0\\.0029779465703162382\ \(0\)\
\-\ surgical\\:\\ 0\\.0029350028925677345\ \(0\)\
\-\ lesion\\:\\ 0\\.0028440444869288475\ \(0\)\
\-\ treatment\\:\\ 0\\.0028261715026158284\ \(0\)\
\-\ is\\:\\ 0\\.002756327345023165\ \(0\)\
\-\ that\\:\\ 0\\.002411733216599385\ \(0\)\
\-\ \\(\\:\\ 0\\.0023606592360910475\ \(0\)\
\-\ \\)\\:\\ 0\\.002331822523246095\ \(0\)\
\-\ by\\:\\ 0\\.0023249524562824753\ \(0\)\
\-\ mass\\:\\ 0\\.0019419297499143212\ \(0\)\
\-\ pain\\:\\ 0\\.00170524210380839\ \(0\)\
\-\ \\.\\:\\ 0\\.0016241617822315287\ \(0\)\
\-\ this\\:\\ 0\\.001570485642670152\ \(0\)\
\-\ old\\:\\ 0\\.0014296316942193704\ \(0\)\
\-\ patient\\:\\ 0\\.0013996600178372352\ \(0\)\
\-\ on\\:\\ 0\\.0011828284515774969\ \(0\)\
